Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.25 DKK | +2.54% | +2.08% | -12.42% |
05:18pm | H LUNDBECK : Lundbeck is well-poised to sail through the transition period | |
09/04 | H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy | MT |
Sales 2024 * | 2.1TCr 304.02Cr 25TCr | Sales 2025 * | 2.18TCr 316.19Cr 26TCr | Capitalization | 3.33TCr 482.19Cr 40TCr |
---|---|---|---|---|---|
Net income 2024 * | 300.2Cr 43Cr 3.63TCr | Net income 2025 * | 342.3Cr 50Cr 4.14TCr | EV / Sales 2024 * | 1.36 x |
Net cash position 2024 * | 465.52Cr 67Cr 5.63TCr | Net cash position 2025 * | 837.28Cr 121.26Cr 10TCr | EV / Sales 2025 * | 1.14 x |
P/E ratio 2024 * |
11.4
x | P/E ratio 2025 * |
9.99
x | Employees | 5,681 |
Yield 2024 * |
2.57% | Yield 2025 * |
2.94% | Free-Float | 30.74% |
Latest transcript on Lundbeck
1 day | +2.20% | ||
Current month | -12.42% | ||
Current year | -12.42% |
Date | Price | Change | Volume |
---|---|---|---|
13/24/13 | 30.25 | +2.54% | 241 078 |
08/24/08 | 29.5 | +0.34% | 65,960 |
07/24/07 | 29.4 | +1.38% | 41,749 |
06/24/06 | 29 | +0.87% | 38,144 |
03/24/03 | 28.75 | -0.17% | 60,251 |
Delayed Quote Nasdaq Copenhagen, May 13, 2024 at 08:29 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.98% | 7.28TCr | |
-1.88% | 2.42TCr | |
+8.80% | 858.65Cr | |
+9.15% | 837.81Cr | |
-17.39% | 809.25Cr | |
+17.69% | 431.58Cr | |
-3.66% | 405.09Cr | |
-2.54% | 393.2Cr | |
+29.14% | 379.47Cr |
- Stock Market
- Equities
- HLUN B Stock
- LUN Stock